์ธํฝ์ฌ
์ธํฝ์ฌ์ ์์ํ์์ ์ฃผ๋ก ๊ฐ์์ฑ์ด ์๋ ๊ทธ๋ ์์ฑ๊ท ๊ฐ์ผ ์น๋ฃ์ ์ฌ์ฉ๋๋ ๊ฒฝ๊ตฌ์ฉ **3์ธ๋ ์ธํ๋ก์คํฌ๋ฆฐ๊ณ** ํญ์์ ์ ๋๋ค. * **ํญ๊ท ์คํํธ๋ผ:** ๋ง์ *์ฅ๋ด์ธ๊ท ๊ณผ*(*๋์ฅ๊ท *, *ํ๋กํ ์ฐ์ค*, *ํด๋ ๋ธ์์๋ผ* ๋ฑ) ๋ฐ ์ผ๋ถ ๊ทธ๋ ์์ฑ๊ท (*์ฐ์์๊ตฌ๊ท * ๋ฑ)์ ๋งค์ฐ ํจ๊ณผ์ ์ ๋๋ค. * **ํ๊ณ:** *๋ น๋๊ท *, *์ฅ๊ตฌ๊ท *, *ํฌ๋์๊ตฌ๊ท *, *๋ณด๋ฅด๋ฐํ ๋ผ* ๋๋ ํ๊ธฐ์ฑ ์ธ๊ท ์๋ ์ผ๋ฐ์ ์ผ๋ก **ํจ๊ณผ๊ฐ ์์ต๋๋ค**. * **์์์ ์ ์ฉ์ฑ:** ๊ฒฝ๊ตฌ ์น๋ฃ๊ฐ ํ์ํ ์ ์ ๋๋ ์๋ก ๊ฐ์ผ์ ์ฃผ๋ก ์ฌ์ฉ๋๋ฉฐ, 1์ฐจ ์ฝ๋ฌผ(ํ๋ฃจ์ค๋กํด๋๋ก ๊ณ ๋๋ ๊ธฐํ ์ธํ๋ก์คํฌ๋ฆฐ๊ณ)์ด ๊ธ๊ธฐ์ด๊ฑฐ๋ ํจ๊ณผ๊ฐ ์์ ๋ ์ฌ์ฉ์ด ์ ํ๋ฉ๋๋ค. > **์์ ์์ :** 3์ธ๋ ์ธํ๋ก์คํฌ๋ฆฐ๊ณ์ ๋ํ ์ธ๊ท ์ ๊ฐ์์ฑ์ ๋งค์ฐ ๋ค์ํ๋ฏ๋ก, ์น๋ฃ๋ฅผ ์์ํ๊ธฐ ์ ์ ์ธํฝ์ฌ ์ ์ฉ ๋์คํฌ๋ ํฌ์๋ฒ์ ์ด์ฉํ ๋ฐฐ์ ๋ฐ ๊ฐ์์ฑ ๊ฒ์ฌ๋ฅผ ์ค์ํ๋ ๊ฒ์ด ๊ฐ๋ ฅํ ๊ถ์ฅ๋ฉ๋๋ค.
์์ฉ ๊ธฐ์ : Cefixime is a **bactericidal** antibiotic that works by inhibiting bacterial cell wall synthesis. * Binds to specific **Penicillin-Binding Proteins (PBPs)** located inside the bacterial cell wall. * **Inhibition of transpeptidation** โ prevents cross-linking of peptidoglycan chains. * **Activation of autolysins** โ leads to bacterial cell wall lysis and death. It is relatively resistant to hydrolysis by many bacterial **beta-lactamases**, allowing it to remain effective against certain resistant gram-negative strains.
๋๋ฌผ ์ข ๋ณ ์ฉ๋
- Susceptible infections ยท 5-12.5 mg/kg PO q12h ยท PO ยท q12h
- Infectious endocarditis ยท 10 mg/kg PO q12h ยท PO ยท q12h ยท Use when documented resistance against or other contraindications for fluoroquinolones and aminoglycosides exist.
- UTI ยท 5 mg/kg PO once to twice daily ยท PO ยท q12h or q24h ยท 7-14 days
- Respiratory, systemic infections ยท 12.5 mg/kg PO q12h ยท PO ยท q12h ยท 7-14 days ยท Duration of treatment dependent on chronicity of infection.
- Susceptible infections ยท 5 mg/kg PO once to twice a day ยท PO ยท q12h or q24h
์ฉ๋์ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์ฐธ๊ณ ์๋ฃ์ ๋๋ค. ํญ์ ์ต์ ๋ผ๋ฒจ๊ณผ ๊ฐ๋ณ ํ์์ ๋ํด ํ์ธํ์ญ์์ค.
ํฌ์ฌ ๊ฒฝ๋ก
๊ธ๊ธฐ
- Hypersensitivity to cefixime or other cephalosporins
์ด์๋ฐ์
- Gastrointestinal distress (vomiting, diarrhea)
- Hypersensitivity reactions (urticaria, pruritus, fever)
์ฝ๋ฌผ ์ํธ์์ฉ
- Probenecid ยท Competitively blocks the tubular secretion of most cephalosporins, thereby increasing serum levels and serum half-lives.
- Salicylates ยท May displace cefixime from plasma protein binding sites; clinical significance is unclear.
๋ชจ๋ํฐ๋ง
- Clinical efficacy (resolution of infection)
- Adverse effects (GI signs, allergic reactions)
- Renal function (in patients with pre-existing renal disease)
๊ณผ์ฉ๋
Cephalosporin overdoses are generally **unlikely to cause significant problems**. * **Expected Signs:** Massive overdoses may result in gastrointestinal distress (vomiting, diarrhea) or hypersensitivity reactions. * **Management:** Treatment is largely supportive and symptomatic. Emptying the stomach may be considered for massive, recent ingestions.
VetSheet ์ฝ๋ฌผ ๋ ํผ๋ฐ์ค๋ ๋ฉดํ ์์ ์ ๋ฌธ๊ฐ๋ฅผ ์ํ ์์ ์์ฌ๊ฒฐ์ ๋ณด์กฐ ๋๊ตฌ์ด๋ฉฐ, ์ ๋ฌธ์ ํ๋จ์ด๋ ์ ์กฐ์ฌ์ ์ต์ ๋ผ๋ฒจ์ ๋์ ํ์ง ์์ต๋๋ค.